Bleakley Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.2M | Buy |
13,931
+2,609
| +23% | +$1.16M | 0.16% | 127 |
|
|
2025
Q1 | $5.49M | Buy |
11,322
+2,847
| +34% | +$1.38M | 0.18% | 115 |
|
|
2024
Q4 | $3.41M | Buy |
8,475
+896
| +12% | +$361K | 0.1% | 170 |
|
|
2024
Q3 | $3.52M | Sell |
7,579
-19,448
| -72% | -$9.04M | 0.11% | 163 |
|
|
2024
Q2 | $12.7M | Sell |
27,027
-850
| -3% | -$398K | 0.37% | 52 |
|
|
2024
Q1 | $11.7M | Buy |
27,877
+5,606
| +25% | +$2.34M | 0.34% | 57 |
|
|
2023
Q4 | $9.06M | Buy |
22,271
+3,819
| +21% | +$1.55M | 0.29% | 65 |
|
|
2023
Q3 | $6.42M | Buy |
18,452
+716
| +4% | +$249K | 0.23% | 86 |
|
|
2023
Q2 | $6.24M | Buy |
17,736
+9,704
| +121% | +$3.41M | 0.19% | 96 |
|
|
2023
Q1 | $2.53M | Buy |
8,032
+513
| +7% | +$162K | 0.08% | 206 |
|
|
2022
Q4 | $2.17M | Buy |
+7,519
| New | +$2.17M | 0.08% | 232 |
|